Cargando…

Fibroblast growth factor receptor 4 induced resistance to radiation therapy in colorectal cancer

In colorectal cancer (CRC), fibroblast growth factor receptor 4 (FGFR4) is upregulated and acts as an oncogene. This study investigated the impact of this receptor on the response to neoadjuvant radiotherapy by analyzing its levels in rectal tumors of patients with different responses to the therapy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahmed, Mohamed A., Selzer, Edgar, Dörr, Wolfgang, Jomrich, Gerd, Harpain, Felix, Silberhumer, Gerd R., Müllauer, Leonhard, Holzmann, Klaus, Grasl-Kraupp, Bettina, Grusch, Michael, Berger, Walter, Marian, Brigitte
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342528/ https://www.ncbi.nlm.nih.gov/pubmed/27650548 http://dx.doi.org/10.18632/oncotarget.12099

Ejemplares similares

Correction: Fibroblast growth factor receptor 4 induced resistance to radiation therapy in colorectal cancer
por: Ahmed, Mohamed A., et al.
Publicado: (2019)

FGF8 induces therapy resistance in neoadjuvantly radiated rectal cancer
por: Harpain, Felix, et al.
Publicado: (2018)

Irinotecan Upregulates Fibroblast Growth Factor Receptor 3 Expression in Colorectal Cancer Cells, Which Mitigates Irinotecan-Induced Apoptosis()()
por: Erdem, Zeynep N., et al.
Publicado: (2017)

A siphon-like retrogastric transverse colon: A case report
por: Harpain, Felix, et al.
Publicado: (2018)

Interaction of FGF9 with FGFR3‐IIIb/IIIc, a putative driver of growth and aggressive behaviour of hepatocellular carcinoma
por: Paur, Jakob, et al.
Publicado: (2020)

Programmed death-ligand 1 expression in rectal cancer
por: Jomrich, G., et al.
Publicado: (2016)

Expression of FGF8, FGF18, and FGFR4 in Gastroesophageal Adenocarcinomas
por: Jomrich, Gerd, et al.
Publicado: (2019)

Fibroblast growth factor receptor 3-IIIc mediates colorectal cancer growth and migration
por: Sonvilla, G, et al.
Publicado: (2010)

FGF5 is expressed in melanoma and enhances malignancy in vitro and in vivo
por: Ghassemi, Sara, et al.
Publicado: (2017)

Importance of Translational Research for Targeting Fibroblast Growth Factor Receptor Signaling in Cancer
por: Holzmann, Klaus, et al.
Publicado: (2019)

Acquired nintedanib resistance in FGFR1-driven small cell lung cancer: role of endothelin-A receptor-activated ABCB1 expression
por: Englinger, Bernhard, et al.
Publicado: (2016)

Inhibin/activin expression in human and rodent liver: subunits α and βB as new players in human hepatocellular carcinoma?
por: Frost, K, et al.
Publicado: (2011)

Fibroblast growth factor receptor 4 promotes glioblastoma progression: a central role of integrin-mediated cell invasiveness
por: Gabler, Lisa, et al.
Publicado: (2022)

Impact of Fibroblast-Derived SPARC on Invasiveness of Colorectal Cancer Cells
por: Drev, Daniel, et al.
Publicado: (2019)

Targeting fibroblast growth factor receptors to combat aggressive ependymoma
por: Lötsch, Daniela, et al.
Publicado: (2021)

Mesothelioma-associated fibroblasts enhance proliferation and migration of pleural mesothelioma cells via c-Met/PI3K and WNT signaling but do not protect against cisplatin
por: Ries, Alexander, et al.
Publicado: (2023)

Comparison of Inflammation-Based Prognostic Scores in a Cohort of Patients with Resectable Esophageal Cancer
por: Jomrich, G., et al.
Publicado: (2017)

Circulating FGF18 is decreased in pleural mesothelioma but not correlated with disease prognosis
por: Mosleh, Berta, et al.
Publicado: (2023)

Sarcopenia and sarcopenic obesity are independent adverse prognostic factors in resectable pancreatic ductal adenocarcinoma
por: Gruber, Elisabeth S., et al.
Publicado: (2019)

The Prognostic Index Independently Predicts Survival in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Resection
por: Gruber, Elisabeth S., et al.
Publicado: (2020)

Correction: Sarcopenia and sarcopenic obesity are independent adverse prognostic factors in resectable pancreatic ductal adenocarcinoma
por: Gruber, Elisabeth S., et al.
Publicado: (2020)

Expression of FGFR1–4 in Malignant Pleural Mesothelioma Tissue and Corresponding Cell Lines and its Relationship to Patient Survival and FGFR Inhibitor Sensitivity
por: Vlacic, Gregor, et al.
Publicado: (2019)

Sphinkeeper Procedure for Treating Severe Faecal Incontinence—A Prospective Cohort Study
por: Dawoud, Christopher, et al.
Publicado: (2021)

Alternative Splicing of Fibroblast Growth Factor Receptor IgIII Loops in Cancer
por: Holzmann, Klaus, et al.
Publicado: (2012)

Phenobarbital Induces Alterations in the Proteome of Hepatocytes and Mesenchymal Cells of Rat Livers
por: Klepeisz, Philip, et al.
Publicado: (2013)

Next generation sequencing: clinical applications in solid tumours
por: Müllauer, Leonhard
Publicado: (2017)

Milestones in pathology—from histology to molecular biology
por: Müllauer, Leonhard
Publicado: (2017)

Molecular Pathology of Cancer: The Past, the Present, and the Future
por: Müllauer, Leonhard
Publicado: (2021)

Prostaglandin E(2) stimulates progression-related gene expression in early colorectal adenoma cells
por: Mauritz, I, et al.
Publicado: (2006)

Systemic Immune-Inflammation Index (SII) Predicts Poor Survival in Pancreatic Cancer Patients Undergoing Resection
por: Jomrich, Gerd, et al.
Publicado: (2019)

Primary and hTERT-Transduced Mesothelioma-Associated Fibroblasts but Not Primary or hTERT-Transduced Mesothelial Cells Stimulate Growth of Human Mesothelioma Cells
por: Ries, Alexander, et al.
Publicado: (2023)

Multimodality locoregional treatment strategies for bridging HCC patients before liver transplantation
por: Györi, Georg P., et al.
Publicado: (2017)

Major vault protein supports glioblastoma survival and migration by upregulating the EGFR/PI3K signalling axis
por: Lötsch, Daniela, et al.
Publicado: (2013)

MELD-Na Alterations on the Liver Transplant Waiting List and Their Impact on Listing Outcome
por: Silberhumer, Gerd R., et al.
Publicado: (2023)

VARIFI—Web-Based Automatic Variant Identification, Filtering and Annotation of Amplicon Sequencing Data
por: Krunic, Milica, et al.
Publicado: (2019)

Genomic alterations in thymoma—molecular pathogenesis?
por: Oberndorfer, Felicitas, et al.
Publicado: (2020)

Trabectedin Is Active against Two Novel, Patient-Derived Solitary Fibrous Pleural Tumor Cell Lines and Synergizes with Ponatinib
por: Ghanim, Bahil, et al.
Publicado: (2022)

Evaluation of efficacy of alemtuzumab in 5 patients with aplastic anemia and/or myelodysplastic neoplasm
por: Füreder, Wolfgang, et al.
Publicado: (2016)

Molecular Profiling of Thymoma and Thymic Carcinoma: Genetic Differences and Potential Novel Therapeutic Targets
por: Enkner, Franz, et al.
Publicado: (2016)

Systemic mastocytosis associated with chronic myelomonocytic leukemia and xanthogranuloma
por: Tschandl, Philipp, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ll4rv6s4rgbpbi0op1j66pot04